< Back to latest news & events

Event

HGF & Shiga Webinar Recording: When “Please amend to fall into line with the granted claims in the US” might not work in Europe and Japan

November 2023

Event date: 20th January 2021

“Please amend to fall into line with the granted claims in the US” is a phrase generally received with caution from attorneys practicing in non-US jurisdictions.

The principle cause for caution is the lack of relative flexibility outside of the US when it comes to supporting arguments for amendments, and the nature of empirical evidence required to be present in the application. Consequently, when a patent application is drafted solely with the USPTO in mind, the lack of flexibility in other jurisdictions can make securing commercially relevant claims scope more difficult in those jurisdictions.

By examining a sample bio-pharma claim and supporting evidence, this presentation aims to provide US practitioners with a practical insight into how far you can push basis (support) and evidence requirements in both Europe and Japan. The presentation will conclude with guidance on how these lessons can inform a drafting style that should make prosecution in both Europe and Japan a more successful exercise.

Click the button below to watch the full webinar.

Speakers 

Dr Masato Iida, Shiga

Mr Kentaro Horie, Shiga

Mr Craig Thomson, HGF

Mr Mike Nelson, HGF

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

IP Ingredients: How food companies are using IP to stay ahead of the GLP-1 curve

The impact of GLP-1 on the food and beverage sector GLP-1 agonists, best-known under the brand names Ozempic® and Wegovy®, are medicines used to treat type 2 diabetes and obesity. …

Read article

European Innovation Remains Strong: The EPO Patent Index 2024

The Patent Index 2024, recently published by the European Patent Office (EPO), provides a rich dataset from which key patent trends can be identified. The data shows that demand for …

Read article

HGF ranked highly recommended in the WIPR Trade Mark Rankings 2025

HGF has been recognised as a leading firm in the recently published World IP Review (WIPR) Trade Mark Rankings 2025. This achievement highlights our continued commitment to excellence in trade …

Read article

T1977/22: Can claims defined by open-ended ranges ever be sufficiently disclosed?

The EPO’s Board of Appeal’s decision in T1977/22 provides an interesting review of the case law concerning the compatibility of whole range sufficiency and claims defined as a result to …

Read article

The draft of The Genetic Technology (Precision Breeding) Regulations 2025 reveals practical details on how to obtain a Precision Bred Organism status

In a recent blog post we discussed the Precision Breeding Regulatory Framework developed by the Food Standards Agency (FSA). Further details on the application process for Precision Bred Organism confirmation …

Read article

A £2.1M Lesson: The Power of Confidential Information

A recent High Court ruling1 serves as a stark reminder of the importance of respecting confidential business information. Hambro Perks, was found guilty of breaching confidentiality and ordered to pay …

Read article